2005
DOI: 10.1590/s1516-93322005000300002
|View full text |Cite
|
Sign up to set email alerts
|

Aspectos biofarmacêuticos da formulação de medicamentos para neonatos: fundamentos da complexação de indometacina com hidroxipropil-beta-ciclodextrina para tratamento oral do fechamento do canal arterial

Abstract: INTRODUÇÃOA investigação farmacêutica tem como intuito o desenvolvimento de novos agentes terapêuticos direcionados à resolução de situações clínicas, integrando conhecimentos pluridisciplinares.A prática de cuidados farmacêuticos possibilita a identificação de situações clínicas para as quais os recursos terapêuticos existentes não são os adequados. Fazer parte da equipe de saúde de uma unidade de cuidados intensivos de neonatologia é um desafio para o farmacêu-tico clínico, confrontado com a necessidade de d… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
4
0
1

Year Published

2009
2009
2023
2023

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 7 publications
(5 citation statements)
references
References 81 publications
0
4
0
1
Order By: Relevance
“…In this case, the heating and consequent reduction of medium viscosity was not performed, and thus, the high viscosity of medium complexation resulted in a reduction in mobility of hindering the formation of DAP/CDs systems due to the presence of polymers. According to Rama et al [18], only complexes with K c between 100 and 1,000 mol L -1 have biological applications, because complexes with K c lower than 100 mol L -1 constitute unstable drug/CD systems, whereas complexes with a K c higher than 1,000 mol L -1 could adversely affect the absorption of the drug. The K c values found in all the systems investigated (Table 3) indicate the formation of inclusion complexes with a suitable stability.…”
Section: Resultsmentioning
confidence: 99%
“…In this case, the heating and consequent reduction of medium viscosity was not performed, and thus, the high viscosity of medium complexation resulted in a reduction in mobility of hindering the formation of DAP/CDs systems due to the presence of polymers. According to Rama et al [18], only complexes with K c between 100 and 1,000 mol L -1 have biological applications, because complexes with K c lower than 100 mol L -1 constitute unstable drug/CD systems, whereas complexes with a K c higher than 1,000 mol L -1 could adversely affect the absorption of the drug. The K c values found in all the systems investigated (Table 3) indicate the formation of inclusion complexes with a suitable stability.…”
Section: Resultsmentioning
confidence: 99%
“…Persistence of this foetal structure beyond 10 days of life is considered abnormal. IM is a drug of choice for closure of the ductus administered by intravenous route [22,23]. The overall idea of our work is to investigate the possibility of using an inclusion complex form of IM to treat PDA by oral administration, with the aim of overcoming, on one hand, the problems of administering intravenous medications to newborns, and on the other hand, the impossibility of using the oral route due to the hydrolysis of IM that occurs at gastric basic pH of newborns of 6-8, and also due to gastrointestinal toxicity.…”
mentioning
confidence: 99%
“…É valido ressaltar que A administração oral das ciclodextrinas naturais não demonstra a indução de toxicidade aguda e, mesmo quando administradas em doses substancialmente elevadas a animais, não resulta em mortalidade. Em testes com ratos, o DL50 (dose letal para 50% dos animais) para administração oral é relatado como superior a 12,5 g/kg para a α-CD, 18,8 g/ kg para a β-CD e 8 g/kg para a γ-CD (Rama et al, 2005).…”
Section: Utilização Das Ciclodextrinas Em Formulações Farmacêuticasunclassified